Skip to main content

Peer Review reports

From: Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial

Original Submission
31 Mar 2014 Submitted Original manuscript
3 Apr 2014 Author responded Author comments - In Ah Choi
Resubmission - Version 2
3 Apr 2014 Submitted Manuscript version 2
12 May 2014 Reviewed Reviewer Report - Alfons den Broeder
25 Jun 2014 Author responded Author comments - In Ah Choi
Resubmission - Version 3
25 Jun 2014 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
2 Jul 2014 Reviewed Reviewer Report - Elizabeth Hensor
10 Sep 2014 Author responded Author comments - In Ah Choi
Resubmission - Version 5
10 Sep 2014 Submitted Manuscript version 5
19 Sep 2014 Reviewed Reviewer Report - Elizabeth Hensor
22 Sep 2014 Reviewed Reviewer Report - Alfons den Broeder
10 Oct 2014 Author responded Author comments - In Ah Choi
Resubmission - Version 6
10 Oct 2014 Submitted Manuscript version 6
Publishing
28 Oct 2014 Editorially accepted
18 Nov 2014 Article published 10.1186/1471-2474-15-375

You can find further information about peer review here.

Back to article page